Indian Pediatrics

, Volume 56, Issue 9, pp 731–732 | Cite as

Is Time Ripe for Hepatitis A Mass Vaccination?

  • Ujjal PoddarEmail author
  • Aathira Ravindranath


Funding: None.


  1. 1.
    WHO Position Paper on Hepatitis A Vaccines — June 2012. Wkly Epidemiol Rec. 2012; 87:261–76Google Scholar
  2. 2.
    Aggarwal R, Goel A. Hepatitis A: Epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28:488–96.CrossRefGoogle Scholar
  3. 3.
    Arankalle V, Mitra M, Bhave S, Ghosh A, Balasubramanian S, Chatterjee S, et al. Changing epidemiology of hepatitis A virus in Indian children. Dovepress. 2014;4:7–13.Google Scholar
  4. 4.
    Murhekar MV, Ashok M, Kanagasabai K, Joshua V, Ravi M, Sabarinathan R, et al. Epidemiology of hepatitis A and hepatitis E based on laboratory surveillance data-India, 2014–2017. Am J Trop Med Hyg. 2018;99:1058–61.CrossRefGoogle Scholar
  5. 5.
    Mohanavalli B, Dhevahi E, Menon T, Malathi S, Thyagarajan SP. Prevalence of antibodies to hepatitis A and hepatitis E virus in urban school children in Chennai. Indian Pediatr. 2003;40:328–31.PubMedGoogle Scholar
  6. 6.
    Sood V, Lal BB, Gupta E, Khanna R, Siloliya MK, Alam S. Hepatitis A virus-related pediatric liver disease burden and its significance in the Indian subcontinent. Indian Pediatr. 2019;56:741–44.PubMedGoogle Scholar
  7. 7.
    Poddar U, Thapa BR, Prasad A, Singh K. Changing spectrum of sporadic acute viral hepatitis in Indian children. J Trop Pediatr. 2002;48:210–3.CrossRefGoogle Scholar
  8. 8.
    Kumar A, Yachha SK, Poddar U, Singh U, Aggarwal R. Does co-infection with multiple viruses adversely inûuence the course and outcome of sporadic acute viral hepatitis in children? J Gastroenterol Hepatol. 2006;21:1533–7.CrossRefGoogle Scholar
  9. 9.
    Poddar U, Thapa BR, Prasad A, Sharma AK, Singh K. Natural history and risk factors in fulminant hepatic failure. Arch Dis Child. 2002;87:54–6.CrossRefGoogle Scholar
  10. 10.
    Jagadisan B, Srivastava A, Yachha SK, Poddar U. Acute on chronic liver disease in children from the developing world: Recognition and prognosis. J Pediatr Gastroenterol Nutr. 2012;54:77–82.CrossRefGoogle Scholar
  11. 11.
    Singh SK, Borkar V, Srivastava A, Mathias A, Yachha SK, Poddar U. Need for recognizing atypical manifestations of childhood sporadic acute viral hepatitis warranting differences in management. Eur J Pediatr. 2019;178:61–7.CrossRefGoogle Scholar
  12. 12.
    Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–8.CrossRefGoogle Scholar
  13. 13.
    Acharya SK, Batra Y, Bhaktal B, Ojha B, Kaur K, Hazari S, et al. Sero epidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: Implications for HAV vaccination. J Gastroenterol Hepatol. 2003;18:822–7.CrossRefGoogle Scholar
  14. 14.
    Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu HA, Postma MJ. Economic evaluations of hepatitis A vaccination in middle-income countries. Expert Rev Vaccines. 2013;12:1479–94.CrossRefGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2019

Authors and Affiliations

  1. 1.Department of Pediatric GastroenterologySanjay Gandhi Postgraduate Institute of Medical SciencesLucknowIndia

Personalised recommendations